The effect of substances known as inducers of neuronal differentiation on cultured human and mouse adipose-derived mesenchymal stem cells (ASCs) and their fate after transplantation into the injured and ischemic mouse brains were studied. ASCs were isolated from the human and mouse adipose tissue. Inducers of neuronal differentiation included β -mercaptoethanol, glial cell linederived neurotrophic factor (GNDF), brain-derived neurotrophic factor (BDNF), retinoic acid (RA), 5-azacytidine, as well as their combinations. Three days after the induction, the phenotype of the induced cells was analyzed using immunocytochemistry and real-time PCR assay for differential expression of specific genes. The induction efficiency was evaluated by the increased transcription of neuronal differentiation markers: nestin, β -III-tubulin (Tub-B), microtubule-associated protein 2 (MAP2), and neuron-specific enolase (ENO2). The expression of marker genes was tested by immunocytochemical analysis. ASC cultivation in the medium with RA or BDNF in combination with 5-azacytidine for a week increased the mRNA and protein levels of nestin, Tub-B, and ENO2. The transplantation of induced mouse ASCs into the mouse brain increased the lifespan of the cells relative to control uninduced cells and promoted their migration from the transplantation site to the recipient cerebral parenchyma. The transplantation of the induced cells into the mouse brain pre-exposed to endothelin-1 promoted a more active cell migration into the surrounding ischemic brain tissue. Thus, ASC exposure to RA or BDNF in combination with 5-azacytidine elevated the transcription of the neuronal differentiation markers and improved the viability and integration of ASCs grafted into the mouse brain.
INTRODUCTION
The adipose stroma contains poorly differentiated precursor cells with the phenotype similar to that of bone marrow mesenchymal stem cells [1] . Adipose-derived mesenchymal stem cells (ASCs) exposed to certain inducers can differentiate in vitro into different cell types: osteoblasts, chondroblasts, adipocytes [2] , hepatocytes, endothelial cells [3] , myoblasts [4] , cardiomyocytes [5] , epithelial cells [6] , and neuronal precursors [7] [8] [9] [10] [11] [12] [13] [14] [15] . In particular, ASCs can be induced to differentiation by retinoic acid [16] and neurotrophic factors [17, 18] . At the same time, the optimum procedure for the induction of ASCs to neuronal differentiation in vitro is still under development, and no studies analyzing different induction procedures in the context of the induced cell transplantation into the damaged brain are available.
Here, we comparatively analyzed the efficiency of neuronal differentiation induced by different factors using published [2] and original protocols involving the exposure to retinoic acid and BDNF in combination with 5-azacytidine, a factor of DNA demethylation. BDNF can induce neuronal stem cell proliferation and differentiation through the binding with the specific cell surface receptor TrkB [19] . Retinoic acid activates the transcription of genes involved in neuronal differentiation through the interaction with the nuclear receptors. However, these factors proved inefficient in the absence of 5-azacytidine.
Thus, analysis of transcription of marker genes allowed us to select efficient inducers of ASC neuronal differentiation. The survival rate and migration ability of cells induced by the chosen techniques were evaluated in vivo by the transplantation of induced ASCs transgenic for GFP into the mouse brain mechanically injured in the course of cell injection and/or exposed to ischemia by endothelin-1 administration.
MATERIALS AND METHODS

Cell Isolation from Adipose Tissue
ASCs were isolated following the protocol by Zuk et al. [20] . Subcutaneous adipose tissue was obtained during abdominal surgery in non-cancer patients with the mean age of 40-60 years. Mouse ASCs were isolated from subcutaneous fat in the inguinal region of Black6 males. The adipose tissue was minced with scissors and digested with collagenase (Invitrogen, 30 U/ml tissue) and proteinase (Gibco, 200 U/ml tissue) for 40 min at 37°C with constant agitation. The suspension was mixed with an equal volume of DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) and centrifuged for 10 min at 1500 x g. The pellet containing the stromal and vascular cell fractions was resuspended in DMEM with 10% FBS and filtered through a 100-mm cell strainer (BD Biosciences, Bedford, MA), after which the cells were inoculated on culture plates (Costar Corning) and incubated at 37°C under 5% CO 2 . The culture medium was replaced daily to select for attached cells. After a monolayer has formed, the cells were harvested by trypsin treatment and were placed in neural differentiation medium at 40-60% confluence.
Cell Staining and Flow Cytometry
ASCs were identified as positive for CD34 (Dako, # C7238), ckit (Dako, # R7145), CD73 (BD, # 550257), CD105 (Serotec, # MCA1557), and TrkB (Abcam, # ab51190). The primary culture and second-passage cells (0.5-1 x 10 cells) were resuspended in 500 ul phosphate buffered saline (PBS) and incubated with the primary antibodies for 40 min. After triple washing with PBS, the cells were incubated with FITC-or PE-labeled secondary antibodies. Cell fluorescence was evaluated by flow cytometry using a MoFlo instrument (DakoCytomation) and analyzed using Summit 4.3 software. An isotype control was included in each experiment, and the staining specificity was confirmed by comparison between control and specific antibody fluorescence. At least 300,000 cells were analyzed for each antigen.
Induction of Neuronal Differentiation
After the second-passage, ASCs were plated on 6-well plates containing DMEM with 10% FBS. One day later, the medium was replaced with DMEM/F12 containing 3% FBS and inducers specified in Table 1 . The induction proceeded for 72 h. 
Analysis of Transcriptional Changes
Total RNA was isolated from the induced cells (RNeasy Mini Kit, Qiagen). cDNA was synthesized following the standard protocol (Fermentas) with oligo-dT primers. Differential expression of genes was analyzed by real-time PCR with SYBR Green detection (Syntol, Russia). The primers used in this work are listed in Table 2 . mRNA levels of the analyzed genes were normalized to two housekeeping genes (GAPDH and β-actin).
Immunofluorescence Staining of Induced ASCs
The differentiation induction was analyzed at the protein level in second-passage ASCs. The cells were transferred to 8-well glass plates (Lab-Tek Chamber Slide, Nalge Nunc), and the inducers were added one day later. After three days, the medium was replaced with a fresh one containing the corresponding inducers, and incubation continued for four days. The cells were fixed with 4% formaldehyde in PBS (Sigma, United States) for 20 min at room temperature and washed three times with PBS. Fixed cells were incubated at room temperature in 1% bovine serum albumin (BSA) with 10% goat serum for 30 min and then with rabbit antibodies against nestin (Chemicon, 1:100), ENO2 (Chenicon, 1:50) or mouse antibodies against β-III-Tubulin (Abcam, 1:100) in PBS supplemented with 0.3% Triton X-100 for 1h. BSA solution (1%) with 10% goat serum was used as the control. After washing with PBS, the cells were incubated for 30 min in PBS containing fluorescent secondary goat antibodies (1:100) against mouse (Alexa 488, Molecular Probes) or rabbit (Alexa 568, Molecular Probes) IgG.
Statistical Analysis
The obtained data that were analyzed using the SigmaStat 9.0 software. Small groups and non-normal distributions were compared using the Mann-Whitney U test. Differences were considered significant at P < 0.05.
Analysis of Induced and Control Cell Fate After Transplantation into Mouse Brain
The ability of ASCs induced to neuronal differentiation to integrate into the mouse brain was analyzed using cells from male Black6 mice transgenic for GFP. GFP-tagged ASCs were cultured in the presence of 5-azacytidine (1 µM) and BDNF (20 ng/ml) (BDNF+5-azacytidine) for 3 days. The cells were injected into the striatum of Black6 mice not expressing GFP. The animals were anesthetized with chloral hydrate and placed in a stereotaxic frame. About 300,000 cells in 1 µl of Hanks solution were slowly delivered into the brain with a microsyringe to the following coordinates: 0 mm AP and 2.5 mm ML. The needle was inserted to a depth of 2.5 mm and withdrawn in steps to a depth of 1.5 mm. After 7, 9, and 11 days, the animals were anesthetized again and perfused through the heart with PBS and then with 4% formaldehyde in PBS. The brain was isolated, fixed in the perfusion fixative for 12 h at 4°C, and soaked in 30% sucrose in PBS. The distribution of grafted cells on 40 µm cryotome-cut coronal sections of the brain was analyzed using an Olympus fluorescent microscope. In supplementary experiments on the fate of grafted Table 2 .
Sequences of Primers cells in ischemic areas of the brain, the suspensions of induced and control cells were delivered immediately after the injection of endothelin-1 (1 µg in 1 ml of saline) which lasted 10 min. Seven days later, the animals were sacrificed and brain sections were cut. The sections were immunohistochemically stained for neuronal differentiation markers β-III-tubulin (Tub-B), doublecortin (DCX), microtubule associated protein 2 (MAP2), and neuron specific enolase (ENO2). Free-floating 40 µm sections were immersed in a solution of antibodies against these markers for 12 h at 4°C. After triple washing in PBS, the sections were immersed in a solution of the secondary antibodies against IgG of the species from which the corresponding primary antibodies were generated. Texas redconjugated secondary antibodies from Jackson ImmunoResearch were used. The sections were mounted on a slide, coated with glycerol, and analyzed using an Olympus fluorescent microscope in the GFP and Texas red channels.
RESULTS AND DISCUSSION
Source Cell Culture Description
The initial population of adipose stromal-vascular cells was heterogeneous. The expression analysis of surface marker antigens indicates that the population contains stem cells with an antigen profile similar to mesenchymal and hematopoietic precursor cells [21, 22, 20] . Isolated ASCs formed a monolayer of fibroblast-like cells in culture. The proportion between mesenchymal and hematopoietic precursor cells was determined in 8-9-day culture. The second-passage population proved to contain ~98% cells with the phenotype of mesenchymal precursor cells (with CD73 and CD105 antigens). While most CD73-positive cells in the primary ASC culture also expressed CD34, a marker of hematopoietic stem cells, its expression was hardly detectable in the second-passage cells. The proportion of cells expressing c-kit, another marker of hematopoietic stem cells, was about 1% in both second-passage and initial ASCs, which indicates the self-renewal capacity of hematopoietic precursors in the population.
Efficiency of Different Differentiation Inducers
We analyzed the levels of the above-mentioned protein markers of neuronal differentiation in human ASCs incubated with different inducers including IBMX (3-isobutyl-1-methylxanthine), β-mercaptoethanol, 5-azacytidine [2, 7, 23] , as well as neurotrophic growth factors BDNF and GDNF ( Table 1) . GFAP was detectable in neither control ASCs nor cells incubated with other studied inducers. Analysis of mRNA levels of other markers demonstrated elevated expression of ENO2, MAP2, Tub-B, and Nestin in cells incubated with retinoic acid or BDNF at the background of 5-azacytidine ( Table 3) . Two optimal combinations of neuronal differentiation inducers were chosen for ASCs: (1) BDNF + 5-azacytidine and (2) retinoic acid + 5-azacytidine (Fig. 1) . The combination of BDNF + 5-azacytidine substantially inducing the development of neuronal properties in ASCs is of particular interest.
ASCs cultured with other inducers of neuronal differentiation demonstrated no increase in the mRNA levels of marker genes ( Table 3) .
The chosen combinations (BDNF or retinoic acid coupled with 5-azacytidine) were studied for the efficiency of controlling ASC differentiation using immunofluorescence staining of induced cells. The incubation with retinoic acid + 5-azacytidine increased the levels of nestin and Tub-B in ASCs, while BDNF + 5-azacytidine increased the cell levels of nestin, Tub-B, as well as neuron-specific enolase ENO2 (Fig. 2) .
The activation of ENO2, MAP2, Tub-B, and nestin expression in ASCs cultured with BDNF or retinoic acid can indicate the induction of neuronal differentiation in these cells.
The capacity of ASCs to respond to neurotrophic factors was evaluated from by the expression of TrkB, the receptor tyrosine kinase for BDNF. This protein is expressed on the neuronal cell bodies, axons, and dendrites in many cerebral structures [24] . In embryogenesis, TrkB is present in the monocyte-dendric cell fraction when the innervation of a particular organ is formed [25] . BDNF binding to this receptor maintains the differentiation and survival of neurons. Second-passage ASCs proved to contain TrkB mRNA (Fig. 3) .
Immunofluorescence staining of Black6 mouse ASCs for the neuronal markers also demonstrated that the induction with BDNF at the background of 5-azacytidine increased their expression (Fig.  4) .
Fate of Induced Mouse ASCs in Mouse Brain
The ability of ASCs induced to neuronal differentiation to integrate into the mouse brain was analyzed using cells from male Black6 mice transgenic for GFP. GFP-tagged ASCs were cultured in the presence of retinoic acid or BDNF at the background of 5-azacytidine for 3 days. The cells were injected into the striatum of GFP-negative Black6 mice. After 7, 9, and 11 days the brain was Fig. (1) . Analysis of mRNA levels of neuronal differentiation markers using real-time RT PCR. mRNA levels of the analyzed genes were normalized to two housekeeping genes (GAPDH and β-actin). The histogram shows the expression of the neuronal markers in human adipose-derived stem cells exposed to the studied inducers. The expression of neuronal differentiation markers is much higher for the combination of BDNF + 5-azacytidine and retinoic acid + 5-azacytidine compared to other inducers. The inducers are indicated on the X axis. Fig. (2) . Immunofluorescence analysis of markers of neuronal differentiation in human ASCs exposed to RA + 5-azacytidine and BDNF + 5-azacytidine. The cells were stained with antibodies against nestin and neuron-specific enolase (red fluorescence) or Tub-B (green fluorescence). All images were produced using the same exposure time. isolated and the distribution of grafted cells was analyzed under a fluorescent microscope. Nine days after the injection, the difference in the distribution of control and induced cells in the brain tissue became apparent. Control cells had no contacts with the recipient tissue and were limited to the injection area. Conversely, ASCs cultured with the inducers migrated into the cerebral parenchyma (Fig. 5) . The difference in the number of green cells between the control and experiment was notable on day 9. Moreover, no control cells could be observed in the striatum 11 days after the injection, while ASCs induced for neuronal differentiation survived in the recipient mouse brain.
The data obtained indicate that the exposure to BDNF or retinoic acid at the background of 5-azacytidine not only induced neuronal differentiation of ASCs and increased the expression of neuronal genes and neurotrophic factors but also increased the survival rate of the grafted cells in the nervous tissue.
Experiments on the introduction of induced and uninduced (control) cells into the mouse brain with experimental focal cerebral ischemia induced by the vasoconstrictor endothelin-1 were conducted. Induced cells proved to be much more active in the ischemic brain than uninduced ones (Fig. 6) . Induced ASCs actively migrated into the cerebral parenchyma, largely along the vessels although free-migrating cells also occurred.
Immunohistochemical staining of the brain sections of experimental animals with grafted GFP-tagged cells demonstrated that only a minor fraction of induced cells (1-2 per section) expressed neuronal markers Tub-B and DCX (Fig. 7) . Tub-B and DCX are microtubule-associated proteins expressed in immature neurons [26] . Normal neuronal precursor cells start to express these 
CONCLUSION
Analysis of transcription profiles of marker genes allowed us to determine the most efficient inducers of neuronal differentiation. The experiments on cultures of human adipose-derived stem cells demonstrated that neuronal inducers BDNF or retinoic acid increase to some extent the expression of neuronal markers; however, a combination of any of them with 5-azacytidine promotes a much more pronounced neuronal differentiation. The efficiency of these combinations has been confirmed in differentiation experiments on cultures of mouse adipose-derived stem cells.
In vivo experiments on the transplantation of GFP-tagged ASCs into the mouse brain demonstrated a higher viability and migration capacity of cells induced by BDNF + 5-azacytidine compared to uninduced ones, which remained viable in the recipient brain no more than 11 days and could not migrate from the compact area of injection. The induced cell migration was notably more active after transplantation into ischemic brain area, where the injury zone was much larger than that after the cell injection without preliminary endothelin-1 administration. Thus, a combination of BDNF or retinoic acid with 5-azacytidine allowed the induced cells to perceive the signals of the cerebral environment and to respond to them by migrating into the injured tissue.
Further studies are needed to identify the intercellular signaling pathways mediating the inducing effect of BDNF and retinoic acid on the neuronal differentiation of ASCs. The absence of expression of neuronal markers in the majority of induced cells grafted into the animal brain indicates that their differentiation can be reversed. Nevertheless, the transplantation of ASCs induced to neuronal differentiation offer a promising approach to nervous tissue repair.
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